home / stock / gene / gene quote
Last: | $1.40 |
---|---|
Change Percent: | 0.71% |
Open: | $1.3901 |
Close: | $1.40 |
High: | $1.58 |
Low: | $1.39 |
Volume: | 23,949 |
Last Trade Date Time: | 07/05/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.4 | $1.3901 | $1.4 | $1.58 | $1.39 | 23,949 | 07-05-2024 |
$1.4 | $1.4 | $1.4 | $1.4038 | $1.35 | 8,865 | 07-04-2024 |
$1.4 | $1.4 | $1.4 | $1.4038 | $1.35 | 8,865 | 07-03-2024 |
$1.37 | $1.49 | $1.37 | $1.49 | $1.37 | 24,931 | 07-02-2024 |
$1.41 | $1.42 | $1.41 | $1.5 | $1.382 | 42,772 | 07-01-2024 |
$1.5 | $1.44 | $1.5 | $1.5 | $1.44 | 18,689 | 06-28-2024 |
$1.48 | $1.46 | $1.48 | $1.5 | $1.45 | 21,889 | 06-27-2024 |
$1.414 | $1.5 | $1.414 | $1.5 | $1.4 | 17,523 | 06-26-2024 |
$1.48 | $1.74 | $1.48 | $1.74 | $1.38 | 123,305 | 06-25-2024 |
$1.72 | $1.7 | $1.72 | $1.75 | $1.65 | 18,772 | 06-24-2024 |
$1.7 | $1.66 | $1.7 | $1.72 | $1.66 | 14,094 | 06-21-2024 |
$1.65 | $1.67 | $1.65 | $1.715 | $1.63 | 15,050 | 06-20-2024 |
$1.72 | $1.7 | $1.72 | $1.79 | $1.615 | 49,003 | 06-19-2024 |
$1.72 | $1.7 | $1.72 | $1.79 | $1.615 | 49,003 | 06-18-2024 |
$1.7 | $1.83 | $1.7 | $1.83 | $1.7 | 49,663 | 06-17-2024 |
$1.82 | $1.81 | $1.82 | $1.8503 | $1.78 | 32,009 | 06-14-2024 |
$1.83 | $1.8001 | $1.83 | $1.8499 | $1.7601 | 83,616 | 06-13-2024 |
$1.79 | $1.85 | $1.79 | $1.88 | $1.75 | 81,333 | 06-12-2024 |
$1.81 | $1.77 | $1.81 | $1.871 | $1.75 | 52,171 | 06-11-2024 |
$1.79 | $1.76 | $1.79 | $1.79 | $1.7 | 18,169 | 06-10-2024 |
News, Short Squeeze, Breakout and More Instantly...
Genetic Technologies Ltd Company Name:
GENE Stock Symbol:
NASDAQ Market:
Genetic Technologies Ltd Website:
CHARLOTTE, N.C., June 25, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, is pleased to share the power of the geneType test in identifyin...
CHARLOTTE, N.C. and MELBOURNE, Australia, June 21, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (NASDAQ:GENE, ASX:GTG, “Company”, “GTG”, or “Genetic Technologies”), a global leader in guideline-driven genomics-based tests in health, wellness and ...
CHARLOTTE, N.C., June 18, 2024 (GLOBE NEWSWIRE) -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE, “Company”, “GTG”), a global leader in genomics-based tests in health, wellness and serious disease, today announces the start of testing operations in the United St...